Company / R&D per Share
Steris R&D per Share History
FY2018-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.05
FY2026
5-year range
$0.77 / $1.09
FY2022-FY2026
Trend
+5.9%
vs FY2025
Sector context
#69 of 108
Health Care
What the data says
At $1.05, Steris's r&d per share ranks #69 of 108 in the Health Care sector. R&D per Share has fluctuated over the past 9 years, ranging from $0.70 in FY2019 to $1.09 in FY2024.
Based on SEC 10-K filings.
1.05 in FY2026 with a 5-year CAGR of +7.3%.
Declined from $1.09 to $1.05 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +0.6%
- 5-Year CAGR
- +7.3%
- 10-Year CAGR
- -
Sector benchmark
#69 of 108 in Health CareTop 64% of 108This company $1.05 Sector average $2.07
▼
-49.0% below sector average
Key checks
Key Insights
- In FY2026, r&d per share increased 5.9% year-over-year.
- Ranks #69 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2019.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $1.05 | +5.9% |
| FY2025 | $1.00 | -8.8% |
| FY2024 | $1.09 | +5.3% |
| FY2023 | $1.04 | +34.9% |
| FY2022 | $0.77 | +3.5% |
| FY2021 | $0.74 | -5.4% |
| FY2020 | $0.78 | +12.0% |
| FY2019 | $0.70 | -5.0% |
| FY2018 | $0.74 | - |
| FY2017 | - | - |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026